Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides - EP2586788

The patent EP2586788 was granted to Genentech on Nov 29, 2017. The application was originally filed on Jul 8, 2008 under application number EP12178200A. The patent is currently recorded with a legal status of "Revoked".

EP2586788

GENENTECH
Application Number
EP12178200A
Filing Date
Jul 8, 2008
Status
Revoked
Dec 16, 2022
Grant Date
Nov 29, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BAYERAug 29, 2018VIERINGADMISSIBLE
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBAug 29, 2018EDERADMISSIBLE
MAIWALDAug 29, 2018MAIWALDADMISSIBLE
MERCK SHARP & DOHMEAug 29, 2018CARPMAELS & RANSFORDADMISSIBLE
OETKEAug 29, 2018WALLINGER RICKER SCHLOTTER TOSTMANNADMISSIBLE
UCB BIOPHARMAAug 29, 2018UCBADMISSIBLE
GLAXO GROUPAug 27, 2018BHOGALADMISSIBLE
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBAug 27, 2018GRUNECKERADMISSIBLE
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBAug 27, 2018GRUNECKER PATENTADMISSIBLE
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBAug 24, 2018-ADMISSIBLE

Patent Citations (182) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO1998US13410-
DESCRIPTIONEP0003089
DESCRIPTIONEP0139383
DESCRIPTIONEP0183070
DESCRIPTIONEP0244234
DESCRIPTIONEP0307247
DESCRIPTIONEP0330191
DESCRIPTIONEP0332865
DESCRIPTIONEP0394538
DESCRIPTIONEP0402226
DESCRIPTIONEP0404097
DESCRIPTIONEP0420937
DESCRIPTIONUS2002004587
DESCRIPTIONUS2002006404
DESCRIPTIONUS2002009444
DESCRIPTIONUS2002012665
DESCRIPTIONUS2002041847
DESCRIPTIONUS2002058029
DESCRIPTIONUS2002128488
DESCRIPTIONUS2002197255
DESCRIPTIONUS2002197256
DESCRIPTIONUS2003021781
DESCRIPTIONUS2003026801
DESCRIPTIONUS2003068664
DESCRIPTIONUS2003082172
DESCRIPTIONUS2003095963
DESCRIPTIONUS2003103971
DESCRIPTIONUS2003133930
DESCRIPTIONUS2003147885
DESCRIPTIONUS2003157108
DESCRIPTIONUS2003175884
DESCRIPTIONUS2003185796
DESCRIPTIONUS2003219433
DESCRIPTIONUS2003219818
DESCRIPTIONUS2004093621
DESCRIPTIONUS2004110704
DESCRIPTIONUS2004132140
DESCRIPTIONUS4515893
DESCRIPTIONUS4560655
DESCRIPTIONUS4657866
DESCRIPTIONUS4676980
DESCRIPTIONUS4767704
DESCRIPTIONUS4816567
DESCRIPTIONUS4861579
DESCRIPTIONUS4927762
DESCRIPTIONUS4943529
DESCRIPTIONUS5091178
DESCRIPTIONUS5091313
DESCRIPTIONUS5122469
DESCRIPTIONUS5500362
DESCRIPTIONUS5545806
DESCRIPTIONUS5545807
DESCRIPTIONUS5569825
DESCRIPTIONUS5595721
DESCRIPTIONUS5622700
DESCRIPTIONUS5625126
DESCRIPTIONUS5633425
DESCRIPTIONUS5639635
DESCRIPTIONUS5661016
DESCRIPTIONUS5672347
DESCRIPTIONUS5677180
DESCRIPTIONUS5693762
DESCRIPTIONUS5714338
DESCRIPTIONUS5721108
DESCRIPTIONUS5721121
DESCRIPTIONUS5725856
DESCRIPTIONUS5736137
DESCRIPTIONUS5776456
DESCRIPTIONUS5783186
DESCRIPTIONUS5807715
DESCRIPTIONUS5821337
DESCRIPTIONUS5843398
DESCRIPTIONUS5843439
DESCRIPTIONUS5849898
DESCRIPTIONUS5854067
DESCRIPTIONUS6015542
DESCRIPTIONUS6037454
DESCRIPTIONUS6090365
DESCRIPTIONUS6120767
DESCRIPTIONUS6171586
DESCRIPTIONUS6194551
DESCRIPTIONUS6224866
DESCRIPTIONUS6242195
DESCRIPTIONUS6287537
DESCRIPTIONUS6368596
DESCRIPTIONUS6399061
DESCRIPTIONUS6410391
DESCRIPTIONUS6455043
DESCRIPTIONUS6528624
DESCRIPTIONUS6538124
DESCRIPTIONUS6602684
DESCRIPTIONUS7169908
DESCRIPTIONUSRE30985E
DESCRIPTIONWO0009160
DESCRIPTIONWO0020864
DESCRIPTIONWO0027428
DESCRIPTIONWO0027433
DESCRIPTIONWO0042072
DESCRIPTIONWO0044788
DESCRIPTIONWO0067795
DESCRIPTIONWO0067796
DESCRIPTIONWO0074718
DESCRIPTIONWO0075348
DESCRIPTIONWO0076542
DESCRIPTIONWO0103734
DESCRIPTIONWO0110460
DESCRIPTIONWO0110461
DESCRIPTIONWO0110462
DESCRIPTIONWO0113945
DESCRIPTIONWO0140309
DESCRIPTIONWO0172333
DESCRIPTIONWO0174388
DESCRIPTIONWO0177342
DESCRIPTIONWO0180884
DESCRIPTIONWO0197858
DESCRIPTIONWO0204021
DESCRIPTIONWO02060955
DESCRIPTIONWO02079255
DESCRIPTIONWO02102312
DESCRIPTIONWO0234790
DESCRIPTIONWO03002607
DESCRIPTIONWO03049694
DESCRIPTIONWO03056012
DESCRIPTIONWO03061694
DESCRIPTIONWO03064621
DESCRIPTIONWO03068821
DESCRIPTIONWO2006083971
DESCRIPTIONWO8700195
DESCRIPTIONWO9003430
DESCRIPTIONWO9100360
DESCRIPTIONWO9110741
DESCRIPTIONWO9220373
DESCRIPTIONWO9301161
DESCRIPTIONWO9304173
DESCRIPTIONWO9308829
DESCRIPTIONWO9316185
DESCRIPTIONWO9400136
DESCRIPTIONWO9503770
DESCRIPTIONWO9519181
DESCRIPTIONWO9523865
DESCRIPTIONWO9600948
DESCRIPTIONWO9627011
DESCRIPTIONWO9630046
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9640210
DESCRIPTIONWO9726912
DESCRIPTIONWO9806248
DESCRIPTIONWO9823761
DESCRIPTIONWO9824893
DESCRIPTIONWO9845331
DESCRIPTIONWO9851793
DESCRIPTIONWO9856418
DESCRIPTIONWO9858964
DESCRIPTIONWO9922764
DESCRIPTIONWO9951642
OPPOSITIONEP0185459
OPPOSITIONEP0414151
OPPOSITIONEP2586788
OPPOSITIONUS2003040095
OPPOSITIONUS2003152966
OPPOSITIONUS2004138424
OPPOSITIONUS2004138428
OPPOSITIONUS2005038231
OPPOSITIONUS2006040348
OPPOSITIONUS2006142549
OPPOSITIONUS2006216790
OPPOSITIONUS2007292411
OPPOSITIONUS7153426
OPPOSITIONWO0204616
OPPOSITIONWO03102132
OPPOSITIONWO2005016968
OPPOSITIONWO2006047340
OPPOSITIONWO2008083288
OPPOSITIONWO2008121616
OPPOSITIONWO2008127305
OPPOSITIONWO2009009523
OPPOSITIONWO9403603
OPPOSITIONWO9726357
OPPOSITIONWO9954440
SEARCHUS2007292411
SEARCHWO9726357

Non-Patent Literature (NPL) Citations (295) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ARTEAGA ET AL., CANCER RES., (1994), vol. 54, pages 3758 - 3765-
DESCRIPTION- ARUFFO, CELL, (1990), vol. 61, pages 1303 - 1313-
DESCRIPTION- BABSON, A.L.; BABSON, S.R., "Kinetic Colorimetric Measurement of Serum Lactate Dehydrogenase Activity", CLIN. CHEM., (1973), vol. 19, pages 766 - 769, XP009119838-
DESCRIPTION- BACHMANN, Cellular and Molecular Biology, AMERICAN SOCIETY FOR MICROBIOLOGY, (1987), vol. 2, pages 1190 - 1219-
DESCRIPTION- BACUS ET AL., CANCER RESEARCH, (1992), vol. 52, pages 2580 - 2589-
DESCRIPTION- BACUS ET AL., MOLECULAR CARCINOGENESIS, (1990), vol. 3, pages 350 - 362-
DESCRIPTION- BARBAS ET AL., PROC NAT. ACAD. SCI. USA, (1994), vol. 91, pages 3809 - 3813-
DESCRIPTION- BARNES; SATO, ANAL. BIOCHEM., (1980), vol. 102, page 255-
DESCRIPTION- BASELGA ET AL., J. CLIN. ONCOL., (1996), vol. 14, pages 737 - 744-
DESCRIPTION- BASS ET AL., PROTEINS, (1990), vol. 8, pages 309 - 314-
DESCRIPTION- BEACH; NURSE, NATURE, (1981), vol. 290, page 140-
DESCRIPTION- BRENNAN ET AL., SCIENCE, (1985), vol. 229, page 81-
DESCRIPTION- BRODEUR, Monoclonal Antibody Production Techniques and Applications, MARCEL DEKKER, INC., (1987), pages 51 - 63-
DESCRIPTION- BRUGGEMANN ET AL., YEAR IN IMMUNOL., (1993), vol. 7, page 33-
DESCRIPTION- BRUGGERMANN ET AL., YEAR IN IMMUNO., (1993), vol. 7, page 33-
DESCRIPTION- C. ANTHONY, THE BIOCHEMISTRY OF METHYLOTROPHS, (1982), page 269-
DESCRIPTION- CARTER ET AL., BIO/TECHNOLOGY, (1992), vol. 10, pages 163 - 167-
DESCRIPTION- CARTER ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, page 4285-
DESCRIPTION- CARTER ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 4285 - 4289-
DESCRIPTION- CASE ET AL., PROC. NATL. ACAD. SCI. USA, (1979), vol. 76, pages 5259 - 5263-
DESCRIPTION- CERIANI ET AL., CANCER RES., (1995), vol. 55, no. 23, pages 5852S - 5856S-
DESCRIPTION- CHADERJIAN ET AL., BIOTECHNOL. PROG., (2005), vol. 21, no. 2, pages 550 - 3-
DESCRIPTION- CHADERJIAN, W.B.; CHIN, E.T.; HARRIS, R.J.; ETCHEVERRY, T.M., "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", BIOTECHNOL. PROG., (2005), vol. 21, pages 550 - 553-
DESCRIPTION- CHOY ET AL., ARTHRITIS RHEUM, (1996), vol. 39, no. 1, pages 52 - 56-
DESCRIPTION- CLACKSON ET AL., NATURE, (1991), vol. 352, pages 624 - 628-
DESCRIPTION- DEMIDEM ET AL., CANCER CHEMOTHERAPY & RADIOPHARMACEUTICALS, (1997), vol. 12, no. 3, pages 177 - 186-
DESCRIPTION- DEVITA ET AL., "Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis", ARTHRITIS & RHEUMATISM, (2002), vol. 46, pages 2029 - 2033-
DESCRIPTION- DHAINAUT ET AL., CRIT. CARE MED., (1995), vol. 23, no. 9, pages 1461 - 1469-
DESCRIPTION- DUCHOSAL ET AL., NATURE, (1992), vol. 355, page 258-
DESCRIPTION- D. WEIR & C. BLACKWELL,, Handbook of Experimental Immunology, BLACKWELL SCIENCE, BOSTON.-
DESCRIPTION- EDWARDS ET AL., "Efficacy and safety of Rituximab, a B-cell targeted chimeric monoclonal antibody: A randomized, placebo controlled trial in patients with rheumatoid arthritis", ARTHRITIS & RHEUMATISM, (2002), vol. 46, no. 9, page S197-
DESCRIPTION- ELLIS ET AL., J. IMMUNOL., (1995), vol. 155, no. 2, pages 925 - 937-
DESCRIPTION- ENGLER, Protein Purification Process Engineering, (1994), pages 37 - 550-
DESCRIPTION- FAHRNER ET AL., BIOTECHNOL. GENET. ENG. REV., (2001), vol. 18, pages 301 - 27-
DESCRIPTION- FELLOUSE, PROC. NATL. ACAD. SCI. USA, (2004), vol. 101, no. 34, pages 12467 - 12472-
DESCRIPTION- FISHWILD ET AL., NATURE BIOTECHNOL., (1996), vol. 14, pages 845 - 851-
DESCRIPTION- FLEER ET AL., BIO/TECHNOLOGY, (1991), vol. 2, pages 968 - 975-
DESCRIPTION- GODING, Monoclonal Antibodies: Principles and Practice, ACADEMIC PRESS, (1986), pages 59 - 1 03-
DESCRIPTION- GODING, Monoclonal Antibodies: Principles and Practice, ACADEMIC PRESS, (1986), pages 59 - 103-
DESCRIPTION- GORDON G.; MACKOW M.C.; LEVY H.R., "On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase", ARCH. BIOCHEM. BIOPHYS., (1995), vol. 318, pages 25 - 29-
DESCRIPTION- GRAHAM ET AL., J. GEN VIROL., (1977), vol. 36, page 59-
DESCRIPTION- GRAZIANO ET AL., J. IMMUNOL., (1995), vol. 155, no. 10, pages 4996 - 5002-
DESCRIPTION- GROMCR S.; URIG S.; BECKER K., "TheTrx System - From Science to Clinic", MEDICINAL RESEARCH REVIEWS, (2004), vol. 24, pages 40 - 89-
DESCRIPTION- GRUBER ET AL., J. IMMUNOL., (1994), vol. 152, page 5368-
DESCRIPTION- HAMMERLING ET AL., Monoclonal Antibodies and T-Cell Hybridomas, ELSEVIER, (1981), pages 563 - 681-
DESCRIPTION- HAMMES G.G.; KOCHAVI D., "Studies of the Enzyme Hexokinase. III. The Role of the Metal Ion", J. AM. CHEM. SOC., (1962), vol. 84, pages 2076 - 2079-
DESCRIPTION- HAMMES G.G.; KOCHAVI D., "Studies of the Enzyme Hexokinase. I. Steady State Kinetics at pH 8", J. AM. CHEM. SOC., (1962), vol. 84, pages 2069 - 2073-
DESCRIPTION- HAM; WALLACE, METH. IN ENZ., (1979), vol. 58, page 44-
DESCRIPTION- HANCOCK ET AL., CANCER RES., (1991), vol. 51, pages 4575 - 4580-
DESCRIPTION- HARRIS, BIOCHEM. SOC. TRANSACTIONS, (1995), vol. 23, pages 1035 - 1038-
DESCRIPTION- HARWERTH ET AL., J. BIOL. CHEM., (1992), vol. 267, pages 15160 - 15167-
DESCRIPTION- HAWKINS ET AL., J. MOL. BIOL., (1992), vol. 226, pages 889 - 896-
DESCRIPTION- HOLLINGER ET AL., PROC. NATL. ACAD SCI. USA, (1993), vol. 90, pages 6444 - 6448-
DESCRIPTION- HOLLINGER ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 6444 - 6448-
DESCRIPTION- HOOGENBOOM ET AL., J. MOL. BIOL., (1991), vol. 227, page 381-
DESCRIPTION- HOOGENBOOM ET AL., MOL. IMMUNOL., (1991), vol. 28, pages 1027 - 1037-
DESCRIPTION- HOURMANT ET AL., TRANSPLANTATION, (1994), vol. 58, pages 377 - 380-
DESCRIPTION- HUDSON ET AL., NAT. MED., (2003), vol. 9, pages 129 - 134-
DESCRIPTION- HURLE; GROSS, CURR. OP. BIOTECH., (1994), vol. 5, pages 428 - 433-
DESCRIPTION- JACKSON ET AL., J. IMMUNOL., (1995), vol. 154, no. 7, pages 3310 - 9-
DESCRIPTION- JAKOBOVITS ET AL., NATURE, (1993), vol. 362, pages 255 - 258-
DESCRIPTION- JAKOBOVITS ET AL., PROC. NATL. ACAD SCI. USA, (1993), vol. 90, page 2551-
DESCRIPTION- JAKOBOVITS ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, page 2551-
DESCRIPTION- JOHANSSON C.; LILLIG C.H.; HOLMGREN A., "Human Mitochondrial Glutaredoxin Reduces S-Glutathionylated Proteins with High Affinity Accepting Electrons from Either Glutathione or Thioredoxin Rcductase", J. BIOL. CHEM., (2004), vol. 279, pages 7537 - 7543-
DESCRIPTION- JOHN C. JOLY ET AL., "Overexpression of Eschericia coli Oxidoreductases Increases Recombinant Insulin-like Growth Factor-1 Accumulation", PROC. NATL. ACAD. SCI. USA, (199803), vol. 95, pages 2773 - 2777-
DESCRIPTION- JONES ET AL., NATURE, (1986), vol. 3, no. 21, pages 522 - 525-
DESCRIPTION- JONES, NATURE, (1986), vol. 321, pages 522 - 525-
DESCRIPTION- JURCIC ET AL., CANCER RES, (1995), vol. 55, no. 23, pages 5908S - 5910S-
DESCRIPTION- JUWEID ET AL., CANCER RES, (1995), vol. 55, no. 23, pages 5899S - 5907S-
DESCRIPTION- KASPRZYK ET AL., CANCER RESEARCH, (1992), vol. 52, pages 2771 - 2776-
DESCRIPTION- KELLY; HYNES, EMBO J., (1985), vol. 4, pages 475 - 479-
DESCRIPTION- KIM ET AL., GROWTH FACTORS, (1992), vol. 7, pages 53 - 64-
DESCRIPTION- KIPRIYANOV; LITTLE, MOLECULAR BIOTECHNOLOGY, (1999), vol. 12, pages 173 - 201-
DESCRIPTION- KIRKPATRICK D.L.; WATSON S.; KUNKEL M.; FLETCHER S.; ULHAQ S.; POWIS G., "Parallel syntheses of disulfide inhibitors of the Trx redox system as potential antitumor agents", ANTICANCER DRUG DES., (1999), vol. 14, pages 421 - 432-
DESCRIPTION- KLAPPER ET AL., ONCOGENE, (1997), vol. 14, pages 2099 - 2109-
DESCRIPTION- KOHLER ET AL., NATURE, (1975), vol. 256, page 495-
DESCRIPTION- KOSTELNY ET AL., LMMUNOL., (1992), vol. 148, no. 5, pages 1547 - 1553-
DESCRIPTION- KOZBOR, J. LMMUNOL., (1984), vol. 133, page 3001-
DESCRIPTION- LAIRD ET AL., "Optimization of BLyS Production and Purification from Eschericia coli", PROTEIN EXPRESSION AND PURIFICATION, (2005), vol. 39, pages 237 - 246-
DESCRIPTION- LAURA C. SIMMONS ET AL., "Expression of Full-length Immunoglobulins in Escherichia coli: Rapid and Efficient Production of Aglycosylated Antibodies", JOURNAL OF IMMUNOLOGICAL METHODS, (2002), vol. 263, pages 133 - 147-
DESCRIPTION- LEANDRO ET AL., "An open study ofB lymphocyte depletion in systemic lupus erythematosus", ARTHRITIS & RHEUMATISM, (2002), vol. 46, no. I, pages 2673 - 2677-
DESCRIPTION- LEANDRO ET AL., "Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion", ANN RHEUM DIS, (2002), vol. 61, pages 833 - 888-
DESCRIPTION- LEANDRO ET AL., "Lymphocyte depletion in rheumatoid arthritis: early evidence for safety, efficacy and dose response", ARTHRITIS & RHEUMATISM, (2001), vol. 44, no. 9, page S370-
DESCRIPTION- LEE ET AL., J. IMMUNOL. METHODS, (2004), vol. 284, no. 1-2, pages 119 - 132-
DESCRIPTION- LEE ET AL., J. MOL. BIOL., (2004), vol. 340, no. 5, pages 1073 - 1093-
DESCRIPTION- LEHRNBECHER ET AL., BLOOD, (1999), vol. 94, page 4220-
DESCRIPTION- LEVINE; PESTRONK, "IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab", NEUROLOGY, (1999), vol. 52, pages 1701 - 1704, XP000942610-
DESCRIPTION- LITTON ET AL., EUR J. IMMUNOL., (1996), vol. 26, no. 1, pages 1 - 9-
DESCRIPTION- LONBERG ET AL., NATURE, (1994), vol. 368, pages 856 - 859-
DESCRIPTION- LONBERG; HUSZAR, INTERN. REV. IMMUNOL., (1995), vol. 13, pages 65 - 93-
DESCRIPTION- LORENZ ET AL., J IMMUNOL., (1996), vol. 156, no. 4, pages 1646 - 1653-
DESCRIPTION- LOUVENCOURT ET AL., J. BACTERIOL., (1983), page 737-
DESCRIPTION- MAIER ET AL., CANCER RES., (1991), vol. 51, pages 5361 - 5369-
DESCRIPTION- MALONEY ET AL., BLOOD, (1996), vol. 88, no. 10, page 637A-
DESCRIPTION- MARKS, BIO/TECHNOLOGY, (1992), vol. 10, pages 779 - 783-
DESCRIPTION- MARKS ET AL., BIO/TECHNOLOGY, (1992), vol. 10, pages 779 - 783-
DESCRIPTION- MARKS ET AL., BIOTECHNOLOGY, (1992), vol. 10, pages 779 - 783-
DESCRIPTION- MARKS ET AL., J MOL. BIOL., (1991), vol. 222, pages 581 - 597-
DESCRIPTION- MARKS ET AL., J. MOL. BIOL., (1992), vol. 222, pages 581 - 597-
DESCRIPTION- MARKS, J. MOL. BIOL., (1991), vol. 222, pages 581 - 597-
DESCRIPTION- MATHER, BIOL. REPROD., (1980), vol. 23, pages 243 - 251-
DESCRIPTION- MATHER ET AL., ANNALS N. Y. ACAD. SCI., (1982), vol. 383, pages 44 - 68-
DESCRIPTION- MCCAFFERTY ET AL., NATURE, (1990), vol. 348, pages 552 - 554-
DESCRIPTION- MCKENZIE ET AL., ONCOGENE, (1989), vol. 4, pages 543 - 548-
DESCRIPTION- Methods in Enzymology, ACADEMIC PRESS, INC.-
DESCRIPTION- MILHAUSEN, M.; LEVY, H.R., "Evidence for an Essential Lysine in G6PD from Leuconostoc mesenteroides", EUR. J. BIOCHEM., (1975), vol. 50, pages 453 - 461-
DESCRIPTION- MILLSTEIN ET AL., NATURE, (1983), vol. 305, pages 537 - 539-
DESCRIPTION- MORIMOTO ET AL., JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, (1992), vol. 24, pages 107 - 117-
DESCRIPTION- MORRISON ET AL., PROC. NATL ACAD. SCI. USA, (1984), vol. 81, page 6851-
DESCRIPTION- MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 6851 - 6855-
DESCRIPTION- MORRISON, NATURE, (1994), vol. 368, pages 812 - 813-
DESCRIPTION- NEUBERGER, NATURE BIOTECHNOL., (1996), vol. 14, page 826-
DESCRIPTION- NIWA R. ET AL., CANCER RES., (2004), vol. 64, no. 6, pages 2127 - 2133-
DESCRIPTION- PEROTTA; ABUEL, "Response of chronic relapsing ITP of 10 years duration to Rituximab", BLOOD, (1998), vol. 10, no. 1, page 88B-
DESCRIPTION- PLEASANTS, J.C.; GUO, W.; RABENSTEIN, D.L., "A comparative study of the kinetics of selenol/diselenide and thiol/disulfide exchange reactions", J. AM. CHEM. SOC. ILL, (1989), pages 6553 - 6558-
DESCRIPTION- PLUCKTHUN, The Pharmacology of Monoclonal Antibodies, SPRINGER-VERLAG, (1994), vol. 113, pages 269 - 315-
DESCRIPTION- PRESTA, CURR. OP. STRUCT. BIOL., (1992), vol. 2, pages 593 - 596-
DESCRIPTION- PRESTA ET AL., J. IMMNOL., (1993), vol. 151, page 2623-
DESCRIPTION- PRESTA ET AL., J. IMMUNOL., (1993), vol. 151, pages 2623 - 2632-
DESCRIPTION- REFF ET AL., BLOOD, (1994), vol. 83, no. 2, pages 435 - 445-
DESCRIPTION- RICHMAN ET AL., CANCER RES., (1995), vol. 55, no. 23, pages 5916S - 5920S-
DESCRIPTION- RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 327-
DESCRIPTION- RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 329-
DESCRIPTION- RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 337-
DESCRIPTION- SARWAL ET AL., N. ENG. J. MED., (20030710), vol. 349, no. 2, pages 125 - 138-
DESCRIPTION- SCHIER ET AL., GENE, (1995), vol. 169, pages 147 - 155-
DESCRIPTION- SHALABY ET AL., EXP. MED., (1992), vol. 175, pages 217 - 225-
DESCRIPTION- SHARKEY ET AL., CANCER RES., (1995), vol. 55, no. 23, pages 5935S - 5945S-
DESCRIPTION- SHAWVER ET AL., CANCER RES., (1994), vol. 54, pages 1367 - 1373-
DESCRIPTION- SHINKAWA ET AL., J BIO. CHEM., (2003), vol. 278, no. 5, pages 3466 - 347-
DESCRIPTION- SHI Y., TRENDS IN GENETICS, (2003), vol. 19, no. 1, pages 9 - 12-
DESCRIPTION- SIDHU ET AL., J. MOL. BIOL., (2004), vol. 338, no. 2, pages 299 - 310-
DESCRIPTION- SIMS ET AL., J. IMMUNOL., (1993), vol. 151, page 2296-
DESCRIPTION- SKERRA; PLUCKTHUN, SCIENCE, (1988), vol. 240, pages 1038 - 1040-
DESCRIPTION- SREEKRISHNA ET AL., J. BASIC MICROBIOL., (1988), vol. 28, pages 265 - 278-
DESCRIPTION- STAMENKOVIC ET AL., CELL, (1991), vol. 66, pages 1133 - 1144-
DESCRIPTION- STANCOVSKI ET AL., PNAS (USA), (1991), vol. 88, pages 8691 - 8695-
DESCRIPTION- STASHI ET AL., "Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idopathic thrombocytopenic purpura", BLOOD, (2001), vol. 98, no. 4, pages 952 - 957-
DESCRIPTION- STEPPE ET AL., TRANSPLANT INTL., (1991), vol. 4, pages 3 - 7-
DESCRIPTION- ST JOHN ET AL., CHEST, (1993), vol. 103, page 932-
DESCRIPTION- TAGLIABUE ET AL., INT. J. CANCER, (1991), vol. 47, pages 933 - 937-
DESCRIPTION- TILBURN ET AL., GENE, (1983), vol. 26, pages 205 - 221-
DESCRIPTION- TRAUNECKER ET AL., EMBO J., (1991), vol. 10, pages 3655 - 3659-
DESCRIPTION- TUTT ET AL., J. IMMUNOL., (1991), vol. 147, page 60-
DESCRIPTION- URLAUB ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, page 4216-
DESCRIPTION- VAN DEN BERG ET AL., BIO/TECHNOLOGY, (1990), vol. 8, page 135-
DESCRIPTION- VASWANI; HAMILTON, ANN. ALLERGY, ASTHMA & IMMUNOL., (1998), vol. 1, pages 105 - 115-
DESCRIPTION- VAUGHAN ET AL., NATURE BIOTECH, (1996), vol. 14, page 309-
DESCRIPTION- VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, pages 1534 - 1536-
DESCRIPTION- WATERHOUSE ET AL., NUC. ACIDS. RES., (1993), vol. 21, pages 2265 - 2266-
DESCRIPTION- WHITESIDES, G.M.; LILBUM, J.E.; SZAJEWSKI, R.P., "Rates of thioldisulfide interchange reactions between mono- and dithiols and Ellman's reagent", J. ORG. CHEM., (1977), vol. 42, pages 332 - 338-
DESCRIPTION- WIPF P.; HOPKINS T.D.; LUNG J.K.; RODRIGUEZ S.; BIRMINGHAM A.; SOUTHWICK E.C.; LAZO J.S.; POWIS G, "New inhibitors of the Trx-TrxR system based on a naphthoquinone spiroketal natural product lead", BIOORG. MED. CHEM. LETT., (2001), vol. 11, pages 2637 - 2641-
DESCRIPTION- XU ET AL., INT. J. CANCER, (1993), vol. 53, pages 401 - 408-
DESCRIPTION- "Yeast Hexokinase : ATP + Hexose --> Hexose-6-phosphate + ADP", MCDONALD, M.R., Methods in Enzymology, ACADEMIC PRESS, (1955), vol. 1, pages 269 - 276-
DESCRIPTION- YELTON ET AL., J. IMMUNOL., (1995), vol. 155, pages 1994 - 2004-
DESCRIPTION- YELTON ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 1470 - 1474-
DESCRIPTION- ZAPATA ET AL., PROTEIN ENG., (1995), vol. 8, no. 10, pages 1057 - 1062-
DESCRIPTION- SOLS, A.; DELAFUENTE, G.; VILLAR-PALASI, C.; ASENSIO, C., "Substrate Specificity and Some Other Properties of Bakers' Yeast Hexokinase", BIOCHIM BIOPHYS ACTA, (1958), vol. 30, doi:doi:10.1016/0006-3002(58)90245-2, pages 92 - 101, XP023378283
DESCRIPTION- LEGRAND, C.; BOUR, J.M.; JACOB, C.; CAPIAUMONT J.; MARTIAL, A.; MARC, A.; WUDTKE, M.; KRETZMER, G.; DEMANGEL, C.; DUVAL, D., "Lactate Dehydrogenase (LDH) Activity of the Number of Dead Cells in the Medium of Cultured Eukaryotic Cells as Marker", J. BIOTECHNOL., (1992), vol. 25, doi:doi:10.1016/0168-1656(92)90158-6, pages 231 - 243, XP024346496
DESCRIPTION- DANA C. ANDERSEN ET AL., "Production Technologies for Monoclonal Antibodies and Their Fragments", CURRENT OPINION IN BIOTECHNOLOGY, (2004), vol. 15, doi:doi:10.1016/j.copbio.2004.08.002, pages 456 - 462, XP004588033
DESCRIPTION- KIRKPATRICK D.L.; KUPERUS M.; DOWDESWELL M.; POTIER N.; DONALD L.J.; KUNKEL M.; BERGGREN M.; ANGULO M.; POWIS G., "Mechanisms of inhibition of the Trx growth factor system by antitumor 2-imidazolyl disulfides", BIOCHEM. PHARMACOL., (1998), vol. 55, doi:doi:10.1016/S0006-2952(97)00597-2, pages 987 - 994, XP002979943
DESCRIPTION- YARIV MAZOR ET AL., "Isolation of Engineered, Full-length Antibodies from Libraries Expressed in Escherichia coli", NATURE BIOTECH., (20070601), vol. 25, doi:doi:10.1038/nbt1296, pages 563 - 565, XP002488027
DESCRIPTION- EDWARDS ET AL., "B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders", BIOCHEM. SOC. TRANS., (2002), vol. 30, no. 4, doi:doi:10.1042/BST0300824, pages 824 - 828, XP002306250
DESCRIPTION- PAUL H. BESSETTE ET AL., "Efficient Folding of Proteins with Multiple Disulfide Bonds in the Escherichia coli cytoplasm", PROC. NATL. ACAD. SCI., (1999), vol. 96, no. 24, doi:doi:10.1073/pnas.96.24.13703, pages 13703 - 08, XP002233564
DESCRIPTION- EDWARDS; CAMBRIDGE, "Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes", RHEUMATOLOGY, (2001), vol. 40, doi:doi:10.1093/rheumatology/40.2.205, pages 205 - 211, XP002348931
OPPOSITION- A. HOLMGREN, "Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide", The Journal of Biological Chemistry, (19890000), vol. 254, no. 9, pages 9627 - 9632, XP055514845-
OPPOSITION- BERGGREN et al., "Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia", Anticancer Research, (19960000), vol. 16, no. 6B, pages 3459 - 3466, XP002062159-
OPPOSITION- CONRADT et al., "Expression of human interleukin-2 in recombinant baby hamster kidney ltk-, and chinese hamster ovary cells /STRUCTURE OF O-LINKED CARBOHYDRATE CHAINS AND THEIR LOCATION WITHIN THE POLYPEPTIDE", J. Biol. Chem., (19890000), vol. 264, no. 29, pages 17368 - 17373, XP003017499-
OPPOSITION- DE JESUS et al., "The Influence of pH on Cell Growth and Specific Productivity of Two CHO Cell Lines Producing Human Anti Rh D IgG", Animal Cell Technology: From Target to Market, (20010000), pages 197 - 199, XP055518622-
OPPOSITION- "Ex- Cell CD CHO Serum-Free Medium for CHO Cells, Chemically Defined", Chemically Defined, SAFC Biosciences TM, (20060000), XP055518415-
OPPOSITION- GLYNN, "Process-Scale Precipitation of Impurities in Mammalian Cell Culture Broth", BioParm International, (20080302), vol. 2008, no. 3, XP055518505-
OPPOSITION- HOLMGREN, "Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide", J. Biol. Chem., (19790000), vol. 254, no. 19, pages 9627 - 9632, XP055514845-
OPPOSITION- MUN et al., "Air sparging of harvested cell culture fluid (HCCF) to prevent antibody disulfide bond reduction BIOT 245", Abstracts of Papers American Chemical Society & 238th American Chemical Society National meeting, vol. 238, (20090818), URL: http://oasys2.confex.com/acs/238nm/techprogram/P1270376.HTM, XP009168192-
OPPOSITION- "Parathyroid hormone", Drugbank, (20071118), Database accession no. DB05829, XP055514766-
OPPOSITION- PLEASANTS et al., "A comparative study of the kinetics of selenol/diselenide and thiol/disulfide exchange reactions", J. Am. Chem. Soc., (19890000), vol. 111, pages 6553 - 6558, XP055518635-
OPPOSITION- Product Specification, Ex- Cell ® ACF CHO Medium, Sigma Aldrich-
OPPOSITION- R K Finn, "AGITATION-AERATION IN THE LABORATORY AND IN INDUSTRY", Finn Bacteriol Rev., (19540101), pages 254 - 274, XP055515363-
OPPOSITION- SALAS-SOLANO et al., "Optimization and validation of a quantitative capillary electrophores is sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies.", Anal. Chem., (20060000), vol. 78, no. 18, XP055518605-
OPPOSITION- SAMBROOK J et al., "Lysis of Cells", Molecular Cloning, (19890000), pages 18.30 - 18.31, XP055514944-
OPPOSITION- Shouichi Higashi, Naomi Matsumoto And Sadaaki Iwanaga, "Conformation of Factor Vila Stabilized by a Labile Disulfide Bond (Cys-310-Cys-329) in the Protease Domain Is Essential for Interaction with Tissue Factor", The Journal of Biological Chemistry, (19971001), vol. 272, no. 41, pages 25724 - 25730, XP055515357-
OPPOSITION- SINGH R et al., "Thiol-disulfide interchange", THE CHEMISTRY OF SULPHUR-CONTAINING FUNCTIONAL GROUPS, John Wiley & Sons Ltd., (19930000), pages 633 - 658, XP003033408-
OPPOSITION- SINGH, "Thiol-disulfide interchange", THE CHEMISTRY OF SULPHUR-CONTAINING FUNCTIONAL GROUPS, (19930000), pages 633 - 658, XP003033408-
OPPOSITION- SMITH et al., "Specific cleavage of immunoglobulin G by copper ions.", Int. J. Peptide Protein Res., (19960000), vol. 48, pages 48 - 55, XP000594105-
OPPOSITION- "Thiol-disulfide interchange", SINGH R., Supplement S. The chemistry of sulphur-containing functional groups, John Wiley & Sons Ltd, (19930000), pages 633 - 658, XP055623232-
OPPOSITION- VOET et al., "2. The reactions of glycolysis", Biochemistry second edition, (19950000), page 447,618,786,811, XP055514967-
OPPOSITION- HUTCHINSON et al., "Shear stress analysis of mammalian cell suspensions for prediction of industrial centrifugation and its verification", Biotechnology and Bioengineering, (20060000), vol. 95, no. 3, pages 483 - 491, XP055514888
OPPOSITION- TREXLER-SCHMIDT et al., "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", Biotechnol. Bioeng., (20100000), vol. 106, no. 3, pages 452 - 461, XP002694206
OPPOSITION- TREXLER SCHMIDT et al., "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", Biotechnology and Bioengineering, (20090000), vol. 106, no. 3, pages 452 - 461, XP002694206
OPPOSITION- TREXLER-SCHMIDT et al., "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", Biotechnology and Bioengineering, (20100000), vol. 106, no. 3, pages 452 - 461, XP002694206
OPPOSITION- TREXLER-SCHMIDT et al., "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", Biotechnology & Bioengineering, (20100000), vol. 106, no. 3, pages 452 - 461, XP002694206
OPPOSITION- TREXLER-SCHMIDT, "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", Biotechnology and Bioengineering, (20100000), vol. 106, no. 3, pages 452 - 461, XP002694206
OPPOSITION- KAO et al., "Mechanism of Antibody Reduction in Cell Culture Production Processes", Biotechnol. Bioeng., (20100000), vol. 107, no. 4, pages 622 - 632, XP002694207
OPPOSITION- KAO et al., "Mechanism of Antibody Reduction in Cell Culture Production Processes", Biotechnology and Bioengineering, (20100000), vol. 107, no. 4, pages 622 - 632, XP002694207
OPPOSITION- KAO, "Mechanism of Antibody Reduction in Cell Culture Production Processes", Biotechnology and Bioengineering, (20100000), vol. 107, no. 4, pages 622 - 632, XP002694207
OPPOSITION- CHOLLANGI et al., "Development of Robust Antibody Purification by Optimizing Protein-A Chromatography in Combination With Precipitation Methodologies", Biotechnology and Bioengineering, (20151100), vol. 112, no. 11, pages 2292 - 2304, XP055519298
OPPOSITION- M. P. Backer, L. S. Metzger, P. L. Slaber, K. L. Nevitt, G. B. Boder, "Large-scale production of monoclonal antibodies in suspension culture", BIOTECHNOLOGY AND BIOENGINEERING, Wiley, US, US, (19881005), vol. 32, no. 8, doi:10.1002/bit.260320807, ISSN 0006-3592, pages 993 - 1000, XP055315406
OPPOSITION- CHUNG W.K. et al., "Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability : Effects of Antibody Disulfide Bond Reduction", Biotechnology and Bioengineering, (20170000), vol. 114, no. 6, pages 1264 - 1274, XP055522850
OPPOSITION- WANG et al., "Effect of Ionic Strength and pH on the Physical and Chemical Stability of a Monoclonal Antibody Antigen-Binding Fragment", JOURNAL OF PHARMACEUTICAL SCIENCES, (20130000), vol. 102, no. 8, pages 2520 - 2537, XP055518558
OPPOSITION- NEERGARD et al., "Stability of Monoclonal Antibodies at High-Concentration: Head-to-Head Comparison of the IgG 1 and IgG 4 Subclass", Journal of Pharmaceutical Sciences, (20130000), vol. 103, no. 1, pages 115 - 127, XP055160507
OPPOSITION- GROMER et al., "The Thioredoxin System - From Science to Clinic", Medicinal Research Reviews, (20040100), vol. 24, no. 1, pages 40 - 89, XP002694209
OPPOSITION- GROMER et al., "The thioredoxin system: From science to clinic", Med. Res. Rev., (20040000), vol. 24, no. 1, pages 40 - 89, XP002694209
OPPOSITION- NECINA, "Capture of human monoclonal antibodies from cell culture supernatant by ion exchange media exhibiting high charge density", Biotechnology and Bioengineering, (19981220), vol. 60, no. 6, pages 689 - 698, XP002616454
OPPOSITION- TEILUM et al., "Disulfide Bond Formation and Folding of Plant Peroxidases Expressed as Inclusion Body Protein in Escherichia coli Thioredoxin Reductase Negative Strains", Protein Expres. Purif., (19990000), vol. 15, pages 77 - 82, XP004441744
OPPOSITION- TEILUM et al., "Disulfide Bond Formation and Folding of Plant Peroxidases Expressed as Inclusion Body Protein in Escherichia coli Thioredoxin Reductase Negative Strains", Protein Expression and Purification, (19990000), vol. 15, pages 77 - 82, XP004441744
OPPOSITION- LEVY et al., "Production of Correctly Folded Fab Antibody Fragment in the Cytoplasm of Escherichia coli trxB gor Mutants via the Coexpression of Molecular Chaperones", Protein Expression and Purification, (20010000), vol. 23, pages 338 - 347, XP055024235
OPPOSITION- LEVY et al., "Production of Correctly Folded Fab Antibody Fragment in the Cytoplasm of Escherichia coli trxB gor Mutants via the Coexpression of Molecular Chaperones", Protein Expression and Purification, (20011100), vol. 23, pages 338 - 347, XP055024235
OPPOSITION- Sung Kwan Yoon ; Yong-Ho Ahn ; Myeong Hyeon Jeong, "Effect of culture temperature on follicle-stimulating hormone production by Chinese hamster ovary cells in a perfusion bioreactor", Applied Microbiology and Biotechnology, Springer, Berlin, DE, Berlin, DE, (20070503), vol. 76, no. 1, doi:10.1007/s00253-007-0985-x, ISSN 1432-0614, pages 83 - 89, XP019538802
OPPOSITION- Fujiki, Y. ; Rathnam, P. ; Saxena, B.B., "Studies on the disulfide bonds in human pituitary follicle-stimulating hormone", BBA - PROTEIN STRUCTURE., ELSEVIER SCIENCE BV, AMSTERDAM., NL, NL, (19800821), vol. 624, no. 2, doi:10.1016/0005-2795(80)90084-7, ISSN 0005-2795, pages 428 - 435, XP023384361
OPPOSITION- THOMSEN et al., "The amino acid sequence of human glucagon", FEBS Letters, (19720000), vol. 21, no. 3, pages 315 - 319, XP055514759
OPPOSITION- IKEBUCHI M. et al., "Effect of medium pH on glutathione redox cycle in cultured human umbilical vein endothelial cells", Metabolism, (19930000), vol. 42, no. 9, pages 1121 - 1126, XP026327640
OPPOSITION- LI et al., "Low level formation of potent catalytic IgG fragments mediated by disulfide bond instability", Mol. Immunol., (19960000), vol. 33, no. 7-8, pages 593 - 600, XP002519389
OPPOSITION- KURANO et al., "Growth behavior of Chinese hamster ovary cells in a compact loop bioreactor: 1. Effects of physical and chemical environments", J. Biotechnol., (19900000), vol. 15, pages 101 - 111, XP001088186
OPPOSITION- LUNDBLAD JL et al., "The effect of processing methods on intravenous immune globulin preparations", Journal of Hospital Infection, (19880800), vol. 12, pages 3 - 15, XP023272026
OPPOSITION- B. Fischer, "Renaturation of recombinant proteins produced as inclusion bodies", Biotech Adv., (19940101), vol. 12, doi:10.1016/0734-9750(94)90292-5, pages 89 - 101, XP055690584
OPPOSITION- OH et al., "Thioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblasts", Archives of Biochemistry and Biophysics, (20040301), vol. 423, pages 218 - 226, XP004488900
OPPOSITION- FOLLMAN et al., "Factorial screening of antibody purification processes using three chromatography steps without protein A", Journal of Chromatography A ., (20040123), vol. 1024, pages 79 - 85, XP002574059
OPPOSITION- ANDERSEN DC et al., "Production technologies for monoclonal antibodies and their fragments", Current Opinion in Biotechnology, (20041000), vol. 15, pages 456 - 462, XP004588033
OPPOSITION- MOWRY et al., "Production and purification of a chimeric monoclonal antibody against botulinum neurotoxin serotype A", Papers in Biotechnology, (20040000), vol. 33, pages 1 - 23, XP004552264
OPPOSITION- MOWRY et al., "Production and purification of a chimeric monoclonal antibody against botulinum neurotoxin serotype A", Protein Expression and Purification, (20040000), vol. 37, pages 399 - 408, XP004552264
OPPOSITION- URIG et al., "On the potential of thioredoxin reductase inhibitors for cancer therapy", Seminars in Cancer Biology, (20060000), vol. 16, pages 452 - 465, XP005727270
OPPOSITION- URIG et al., "On the potential of thioredoxin reductase inhibitors for cancer therapy", Semin. Cancer Biol., (20060000), vol. 16, pages 452 - 465, XP005727270
OPPOSITION- VERMEER et al., "The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein", Biophysical Journal,, (20000000), vol. 78, pages 394 - 404, XP055518561
OPPOSITION- POWIS et al., "Thioredoxin redox control of cell growth and death and the effects of inhibitors", Chem-Biol Interact., (19980000), vol. 111-112, pages 23 - 34, XP002519386
OPPOSITION- POWIS et al., "Thioredoxin redox control of cell growth and death and the effects of inhibitors", Chemico-Biological Interactions, (19980000), vol. 111-112, pages 23 - 34, XP002519386
OPPOSITION- "Reduction of disulfides by thioredoxin. Exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action", Holmgren, J. Biol. Chem., (19790000), vol. 254, no. 18, pages 9113 - 9119, XP055515419
OPPOSITION- MAGNUSSEN et al., "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses", Mol Immunology, (19970000), vol. 34, no. 10, pages 709 - 719, XP002497450
OPPOSITION- MAGNUSSON C. G. M. et al., "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses", Molecular Immunology, (19970000), vol. 34, no. 19, pages 709 - 717, XP002497450
OPPOSITION- MAGNUSSON et al., "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses", Molecular Immunology, (19970000), vol. 34, no. 10, pages 709 - 717, XP002497450
OPPOSITION- MAGNUSSON et al., "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses", MOLECULAR IMMUNOLOGY, (19970000), vol. 34, no. 10, pages 709 - 717, XP002497450
OPPOSITION- MAGNUSSON et al., "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses", Molecular Immunology, (19970700), vol. 34, no. 10, pages 709 - 717, XP002497450
OPPOSITION- MAGNUSSON et al., "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses", Mol. Immunol., (19970000), vol. 34, no. 10, pages 709 - 717, XP002497450
OPPOSITION- MAGNUSSON, "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses", Molecular Immunology, (19970000), vol. 34, no. 10, pages 709 - 717, XP002497450
OPPOSITION- NORDBERG et al., "Reactive oxygen species, antioxidants, and the mammalian thioredoxin system", Free Radical Biology & Medicine, (20010000), vol. 31, no. 11, pages 1287 - 1312, XP002519388
OPPOSITION- NORDBERG et al., "Reactive oxygen species, antioxidants, and the mammalian thioredoxin system", Free Radical Bio. Med., (20010000), vol. 31, no. 11, pages 1287 - 1312, XP002519388
OPPOSITION- A. HOLMGREN, "Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide", Structure, (19950000), vol. 3, no. 3, pages 239 - 2434, XP004587846
OPPOSITION- HOLMGREN, "Thioredoxin structure and mechanism: conformational changes on oxidation of the active-side sulfhydryls to a disulfide", Minireview, Structure, (19950300), vol. 3, no. 3, pages 239 - 243, XP004587846
OPPOSITION- TSUJI et al., "Characterization of disulfide bonds in recombinant proteins: reduced human interleukin 2 in inclusion bodies and its oxidative refolding", Biochemistry, (19870000), vol. 26, pages 3129 - 3134, XP002056324
OPPOSITION- ZHANG et al., "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnology Progress, (20020000), vol. 18, no. 3, pages 509 - 513, XP002500112
OPPOSITION- Z HANG et al., "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnol. Prog., (20020000), vol. 18, pages 509 - 513, XP002500112
OPPOSITION- ZHANG et al., "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnol . Prog., (20020000), vol. 18, pages 509 - 513, XP002500112
OPPOSITION- ZHANG et al., "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnol. Prog, (20020000), vol. 18, pages 509 - 513, XP002500112
OPPOSITION- ZHANG et al., "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnol. Prog., (20020000), vol. 18, pages 509 - 513, XP002500112
OPPOSITION- ZHANG W et al., "Free Sulfhydryl in Recombinant Monoclonal Antibodies", Biotechnol. Prog., (20020000), vol. 18, no. 3, pages 509 - 513, XP002500112
OPPOSITION- CHADERJIAN et al., "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", Biotechnol. Prog., (20050000), vol. 21, no. 2, pages 550 - 553, XP002500111
OPPOSITION- CHADERJIAN et al., "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", Biotechnol. Prog., (20050000), vol. 21, pages 550 - 553, XP002500111
OPPOSITION- CHADERJIAN W.B. et al., "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", Biotechnol. Prog., (20050000), vol. 21, pages 550 - 553, XP002500111
OPPOSITION- YIGZAW et al., "Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification", Biotechnol. Prog, (20060000), vol. 22, pages 288 - 296, XP002472117
OPPOSITION- ROUSH, "Advances in Primary Recovery: Centrifugation and Membrane Technology", Biotechnological Progress, (20080415), vol. 24, no. 3, pages 488 - 495, XP055090116
OPPOSITION- ROUSH DJ et al., "Advances in Primary Recovery: Centrifugation and Membrane Technology", Biotechnology Progress, (20080415), vol. 24, pages 488 - 495, XP055090116
OPPOSITION- ROUSH et al., "Advances in Primary Recovery: Centrifugation and Membrane Technology", Biotechnology Progress,, (20080000), vol. 24, no. 3, pages 488 - 495, XP055090116
OPPOSITION- ROUSH et al., "Advances in Primary Recovery: Centrifugation and Membrane Technology", Biotechnol. Prog., (20080000), vol. 24, pages 488 - 495, XP055090116
OPPOSITION- SINGH R et al., "A Reagent for Reduction of Disulfide Bonds in Proteins That Reduces Disulfide Bonds Faster Than Does Dithiothreitol", Journal of Organic Chemistry, (19910300), vol. 56, pages 2332 - 2337, XP000601977
OPPOSITION- WHITESIDE et al., "Rates of thiol-disulfide interchange reactions between mono- and dithiols and Ellman's reagent", J. Org. Chem., (19770000), vol. 42, no. 2, pages 332 - 338, XP055518464
OPPOSITION- WHITESIDES et al., "Rates of thiol-disulfide interchange reactions between mono- and dithiols and Ellman's reagent", J. Org. Chem., (19760000), vol. 42, no. 2, pages 332 - 338, XP055518630
OPPOSITION- WHITESIDES GM et al., "Rates of thioldisulfide interchange reactions between mono- and dithiols and Ellman's reagent", J. Org. Chem., (19770000), vol. 42, pages 332 - 338, XP055518464
OPPOSITION- BORYS MC et al., "Culture pH Affects Expression Rates and Glycosylation of Recombinant Mouse Placental Lactogen Proteins by Chinese Hamster Ovary (CHO) cells", Biotechnology, (19930600), vol. 11, no. 6, pages 720 - 724, XP002486307
OPPOSITION- SEVIER C.S. et al., "Formation and transfer of disulphide bonds in living cells", Nat. Rev. Mol. Cell Biol., (20020000), vol. 3, pages 836 - 847, XP055622837
OPPOSITION- KERBLAT et al., "Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases", Immunology, (19990000), vol. 97, pages 62 - 68, XP002519384
OPPOSITION- KERBLAT et al., "Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases", Immunology, (19990500), vol. 97, no. 1, pages 62 - 68, XP002519384
OPPOSITION- MAITA N. et al., "Human α-l-iduronidase uses its own N -glycan as a substrate-binding and catalytic module", PNAS, (20130000), vol. 110, no. 36, doi:10.1073/pnas.1306939110, pages 14628 - 14633, XP055622811
OPPOSITION- ZHONG et al., "Essential Role of Selenium in the Catalytic Activities of Mammalian Thioredoxin Reductase Revealed by Characterization of Recombinant Enzymes with Selenocysteine Mutations", JBC, (20000000), vol. 275, no. 24, pages 18121 - 18128, XP055518546
OPPOSITION- XIA et al., "The Mammalian Cytosolic Selenoenzyme Thioredoxin Reductase Reduces Ubiquinone", J. Biol. Chem., (20030000), vol. 278, pages 2141 - 2146, XP055518085
OPPOSITION- XIA L. et al., "The Mammalian Cytosolic Selenoenzyme Thioredoxin Reductase Reduces Ubiquinone", J. Biol. Chem., (20030000), vol. 278, pages 2141 - 2146, XP055518085
OPPOSITION- XIA, "The Mammalian Cytosolic Selenoenzyme Thioredoxin Reductase Reduces Ubiquinone", The Journal of Biological Chemistry, (20030000), vol. 278, no. 4, pages 2141 - 2146, XP055518085
OPPOSITION- STARKS et al., "Atomic-resolution crystal structure of thioredoxin from the acidophilic bacterium Acetobacter aceti", Protein Sci., (20070000), vol. 16, no. 1, pages 92 - 98, XP002694208
OPPOSITION- LYDERSEN, "Acid precipitation of mammalian cell fermentation broth", Annals of the New York Academy of Sciences, (19940000), vol. 75, pages 222 - 231, XP009033271
OPPOSITION- LYDERSEN B.K. et al., "Acid precipitation of mammalian cell fermentation broth", Ann N. Y. Acad Sci., (19940000), vol. 75, pages 222 - 231, XP009033271
OPPOSITION- LYDERSEN et al., "Acid precipitation of mammalian cell fermentation broth", Annals of the New York Academy of Sciences, (19940000), vol. 745, no. 1, pages 222 - 231, XP009033271
OPPOSITION- LYDERSEN et al., "Acid precipitation of mammalian cell fermentation broth", Annals of the New York Academy of Sciences, (19940000), vol. 745, pages 222 - 231, XP009033271
OPPOSITION- LYDERSEN et al., "Acid precipitation of mammalian cell fermentation broth", Annals of the New York Academy of Sciences,, (19941130), vol. 745, pages 222 - 231, XP009033271
OPPOSITION- LYDERSEN et al., "Acid precipitation of mammalian cell fermentation broth", Annals of the New York Academy of Sciences, vol. 745, no. 1, pages 222 - 231, XP009033271
OPPOSITION- LYDERSEN et al., "Acid precipitation of mammalian cell fermentation broth", Ann NY Acad of Sci., (19940000), vol. 745, pages 222 - 231, XP009033271
OPPOSITION- LYDERSEN et al., "Acid precipitation of mammalian cell fermentation broth", Ann. NY Acad. Sci., (19940000), vol. 745, no. 1, pages 222 - 231, XP009033271
OPPOSITION- LYDERSEN et al., "Acid precipitation of mammalian cell fermentation broth", Ann. NY Acad. Sci., (19941130), vol. 745, pages 222 - 231, XP009033271
OPPOSITION- POWIS et al., "Properties and biological activities of thioredoxins", Annu. Rev. Pharmacol. Toxicol., (20010000), vol. 41, pages 261 - 295, XP002519387
OPPOSITION- CROMWELL et al., "Protein Aggregation and Bioprocessing", The AAPS Journal, (20060915), vol. 8, no. 3, pages E572 - E579, XP002557046
OPPOSITION- BOBOVNIKOVA et al., "Characterization of soluble, disulfide bond-stabilized, prokaryotically depressed human thyrotropin receptor ectodomain", Endocrinology, (19970000), vol. 138, no. 2, pages 588 - 593, XP002519385
OPPOSITION- HUTTERER et al., "Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects", mAbs, (20130000), vol. 5, no. 4, pages 608 - 613, XP055514733
SEARCH- MUN MELISSA S ET AL, "BIOT 245-Air sparging of harvested cell culture fluid (HCCF) to prevent antibody disulfide bond reduction", ABSTRACTS OF PAPERS AMERICAN CHEMICAL SOCIETY, & 238TH AMERICAN-CHEMICAL-SOCIETY NATIONAL MEETING; WASHINGTON, DC, USA; AUGUST 16 -20, 2009, (200908), vol. 238, ISSN 0065-7727, pages 245 - BIOT, XP009168192 [T] 1-20 * the whole document *-
SEARCH- SMITH M A ET AL, "SPECIFIC CLEAVAGE OF IMMUNOGLOBULIN G BY COPPER IONS", INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, MUNKSGAARD, COPENHAGEN, DK, (19960701), vol. 48, no. 1, ISSN 0367-8377, pages 48 - 55, XP000594105 [A] 1-20-
SEARCH- TREXLER-SCHMIDT M ET AL, "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", BIOTECHNOLOGY AND BIOENGINEERING 20100615 JOHN WILEY AND SONS INC. USA, (20100615), vol. 106, no. 3, doi:10.1002/BIT.22699, pages 452 - 461, XP002694206 [T] 1-20 * the whole document *
SEARCH- KAO YUNG-HSIANG ET AL, "Mechanism of Antibody Reduction in Cell Culture Production Processes", BIOTECHNOLOGY AND BIOENGINEERING, (201011), vol. 107, no. 4, pages 622 - 632, XP002694207 [T] 1-20 * the whole document *
SEARCH- GROMER STEPHAN ET AL, "The thioredoxin system: From science to clinic.", MEDICINAL RESEARCH REVIEWS, (200401), vol. 24, no. 1, ISSN 0198-6325, pages 40 - 89, XP002694209 [A] 1-20 * the whole document *
SEARCH- TEILUM K ET AL, "Disulfide Bond Formation and Folding of Plant Peroxidases Expressed as Inclusion Body Protein inEscherichia coliThioredoxin Reductase Negative Strains", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, (19990201), vol. 15, no. 1, ISSN 1046-5928, pages 77 - 82, XP004441744 [A] 1-20 * abstract * * page 77, right-hand column, last sentence of last full paragraph. *
SEARCH- LI LAN ET AL, "Low level formation of potent catalytic IgG fragments mediated by disulfide bond instability", MOLECULAR IMMUNOLOGY, (1996), vol. 33, no. 7-8, ISSN 0161-5890, pages 593 - 600, XP002519389 [A] 1-20 * abstract *
SEARCH- URIG S ET AL, "On the potential of thioredoxin reductase inhibitors for cancer therapy", SEMINARS IN CANCER BIOLOGY, SAUNDERS SCIENTIFIC PUBLICATIONS, PHILADELPHIA, PA, US, vol. 16, no. 6, ISSN 1044-579X, (20061201), pages 452 - 465, (20061201), XP024908082 [A] 1-20 * the whole document *
SEARCH- POWIS G ET AL, "Thioredoxin redox control of cell growth and death and the effects of inhibitors", CHEMICO-BIOLOGICAL INTERACTIONS 19980424 IE, (19980424), vol. 111-112, ISSN 0009-2797, pages 23 - 34, XP002519386 [A] 1-20 * the whole document *
SEARCH- NORDBERG J ET AL, "Reactive oxygen species, antioxidants, and the mammalian thioredoxin system.", FREE RADICAL BIOLOGY & MEDICINE 1 DEC 2001, (20011201), vol. 31, no. 11, ISSN 0891-5849, pages 1287 - 1312, XP002519388 [A] 1-20 * the whole document *
SEARCH- SALAS-SOLANO OSCAR ET AL, "Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies.", ANALYTICAL CHEMISTRY 15 SEP 2006, (20060915), vol. 78, no. 18, ISSN 0003-2700, pages 6583 - 6594, XP002519390 [A] 1-20 * abstract *
SEARCH- ZHANG WEI ET AL, "Free sulfhydryl in recombinant monoclonal antibodies", BIOTECHNOLOGY PROGRESS, (200205), vol. 18, no. 3, ISSN 8756-7938, pages 509 - 513, XP002500112 [A] 1-20
SEARCH- CHADERJIAN WENDY B ET AL, "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", BIOTECHNOLOGY PROGRESS, (200503), vol. 21, no. 2, ISSN 8756-7938, pages 550 - 553, XP002500111 [AD] 1-20 * the whole document *
SEARCH- KERBLAT I ET AL, "Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases", IMMUNOLOGY, (199905), vol. 97, no. 1, ISSN 0019-2805, pages 62 - 68, XP002519384 [A] 1-20 * the whole document *
SEARCH- STARKS COURTNEY M ET AL, "Atomic-resolution crystal structure of thioredoxin from the acidophilic bacterium Acetobacter aceti", PROTEIN SCIENCE, (200701), vol. 16, no. 1, ISSN 0961-8368, pages 92 - 98, XP002694208 [A] 1-20 * abstract *
SEARCH- POWIS G ET AL, "Properties and biological activities of thioredoxins", ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 2001 US, (2001), vol. 41, ISSN 0362-1642, pages 261 - 295, XP002519387 [A] 1-20 * the whole document *
SEARCH- BOBOVNIKOVA Y ET AL, "Characterization of soluble, disulfide bond-stabilized, prokaryotically depressed human thyrotropin receptor ectodomain", ENDOCRINOLOGY, (1997), vol. 138, no. 2, ISSN 0013-7227, pages 588 - 593, XP002519385 [A] 1-20 * abstract * * page 588, column R, paragraphs 1-6 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents